Laurence M Binder, Philip K Martin, Ryan W Schroeder
{"title":"When failure on one performance validity test demonstrates invalid neuropsychological responding.","authors":"Laurence M Binder, Philip K Martin, Ryan W Schroeder","doi":"10.1080/13854046.2025.2570302","DOIUrl":null,"url":null,"abstract":"<p><p><b>Objective:</b> A commonly held rule in neuropsychology is that two performance validity test (PVT) failures are required to determine response invalidity. This study assessed whether there are exceptions to this rule based on the PVT administered and the magnitude of the failure. <b>Method:</b> 261 adult examinees completed a battery of neuropsychological tests as part of their clinical or forensic evaluations. These batteries contained 4-12 PVTs (mean = 8.1) and always included both the Test of Memory Malingering (TOMM) and Reliable Digit Span (RDS). Analyses were performed to assess associations between PVT failures. <b>Results:</b> 16.5% of examinees failed the TOMM at conventional cutoffs; 97.7% of these individuals failed at least one other PVT. RDS was failed by 14.2% of examinees; 75.7% of whom failed at least one other PVT. The TOMM was significantly more strongly associated than RDS with at least one additional PVT failure with a medium effect size. At a TOMM Trial 2 or Retention score of <43, 100% of examinees failed at least one other PVT. At an RDS cutoff of <4, 100% of individuals failed at least one additional PVT; this was not useful, because only one individual produced that score. <b>Conclusions:</b> While use of multiple PVTs is recommended, the current results suggest that failure on the TOMM, especially with Trial 2 or Retention <43, is sufficient for determining that test data are invalid if multiple PVTs are not available for analysis. Further research is recommended to cross-validate these findings and generalize the results to other PVTs.</p>","PeriodicalId":55250,"journal":{"name":"Clinical Neuropsychologist","volume":" ","pages":"1-12"},"PeriodicalIF":2.7000,"publicationDate":"2025-10-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical Neuropsychologist","FirstCategoryId":"102","ListUrlMain":"https://doi.org/10.1080/13854046.2025.2570302","RegionNum":3,"RegionCategory":"心理学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Objective: A commonly held rule in neuropsychology is that two performance validity test (PVT) failures are required to determine response invalidity. This study assessed whether there are exceptions to this rule based on the PVT administered and the magnitude of the failure. Method: 261 adult examinees completed a battery of neuropsychological tests as part of their clinical or forensic evaluations. These batteries contained 4-12 PVTs (mean = 8.1) and always included both the Test of Memory Malingering (TOMM) and Reliable Digit Span (RDS). Analyses were performed to assess associations between PVT failures. Results: 16.5% of examinees failed the TOMM at conventional cutoffs; 97.7% of these individuals failed at least one other PVT. RDS was failed by 14.2% of examinees; 75.7% of whom failed at least one other PVT. The TOMM was significantly more strongly associated than RDS with at least one additional PVT failure with a medium effect size. At a TOMM Trial 2 or Retention score of <43, 100% of examinees failed at least one other PVT. At an RDS cutoff of <4, 100% of individuals failed at least one additional PVT; this was not useful, because only one individual produced that score. Conclusions: While use of multiple PVTs is recommended, the current results suggest that failure on the TOMM, especially with Trial 2 or Retention <43, is sufficient for determining that test data are invalid if multiple PVTs are not available for analysis. Further research is recommended to cross-validate these findings and generalize the results to other PVTs.
期刊介绍:
The Clinical Neuropsychologist (TCN) serves as the premier forum for (1) state-of-the-art clinically-relevant scientific research, (2) in-depth professional discussions of matters germane to evidence-based practice, and (3) clinical case studies in neuropsychology. Of particular interest are papers that can make definitive statements about a given topic (thereby having implications for the standards of clinical practice) and those with the potential to expand today’s clinical frontiers. Research on all age groups, and on both clinical and normal populations, is considered.